The Irell & Manella Graduate School of Biological Sciences trains students to apply their talents and creativity toward advancing our knowledge of deadly diseases…and finding cures.
City of Hope has an enduring commitment to continuing medical education, sharing advances in cancer research and treatment with the healthcare community through conferences and symposia.
We provide an innovative series of educational programs for nurses, radiation therapists, pharmacists, cancer researchers and others.
City of Hope offers a range of valuable programs and training for postdoctoral trainees, medical professionals and our own staff.
City of Hope offers a distinctive setting for research, one in which scientists’ work is consistently applied to finding novel therapies for life-threatening diseases.
Clinical trials being presented by City of Hope physicians and researchers at the 2016 annual meeting of the American Society of Hematology (ASH), could ultimately lead to innovative therapeutic approaches that improve survival and quality of life for patients with those and other diseases.
There has been great progress made in the fight against HIV/AIDS, and continued efforts to end this global epidemic. Advances, such as anti-retroviral therapy, have revolutionized HIV treatment. Now, researchers are edging closer to the ultimate goal: a cure.
In this Q and A, Steven T. Rosen, M.D., provost and chief scientific officer for City of Hope, answers questions about the importance of precision of medicine in the fight against cancer and how the City of Hope and TGen alliance will advance research and treatment using this approach.
Despite the fact that overall rates of lung cancer have been declining in the United States for some time, disparities in incidence and outcome along racial lines still exist, particularly among the African American population. City of Hope's thoracic surgeon, Loretta Erhunmwunsee, M.D., discusses research findings.
City of Hope, a world-renowned independent research and cancer and diabetes treatment center, and Translational Genomics Research Institute (TGen), a leading biomedical research institute, announced today that they have formed an alliance to make precision medicine a reality for patients.